Lemonade, Inc. (NYSE:LMND – Get Free Report) insider John Sheldon Peters sold 2,667 shares of the business’s stock in a transaction dated Wednesday, December 3rd. The stock was sold at an average price of $72.37, for a total transaction of $193,010.79. Following the completion of the sale, the insider directly owned 74,325 shares of the company’s stock, valued at $5,378,900.25. The trade was a 3.46% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.
John Sheldon Peters also recently made the following trade(s):
- On Tuesday, December 2nd, John Sheldon Peters sold 2,677 shares of Lemonade stock. The stock was sold at an average price of $72.74, for a total value of $194,724.98.
- On Monday, November 24th, John Sheldon Peters sold 3,798 shares of Lemonade stock. The shares were sold at an average price of $73.25, for a total transaction of $278,203.50.
- On Thursday, November 20th, John Sheldon Peters sold 18,930 shares of Lemonade stock. The stock was sold at an average price of $72.77, for a total value of $1,377,536.10.
Lemonade Stock Performance
NYSE:LMND opened at $78.97 on Friday. The business has a fifty day moving average of $63.18 and a 200-day moving average of $51.46. The stock has a market cap of $5.90 billion, a price-to-earnings ratio of -33.04 and a beta of 2.13. Lemonade, Inc. has a 1 year low of $24.31 and a 1 year high of $83.77.
Wall Street Analysts Forecast Growth
A number of brokerages recently commented on LMND. Keefe, Bruyette & Woods boosted their price objective on shares of Lemonade from $35.00 to $40.00 and gave the company an “underperform” rating in a research report on Tuesday, November 25th. Cantor Fitzgerald raised Lemonade to a “strong-buy” rating in a research report on Wednesday, August 13th. JMP Securities set a $80.00 target price on Lemonade in a report on Monday, November 24th. Citizens Jmp increased their target price on shares of Lemonade from $60.00 to $80.00 and gave the company a “market outperform” rating in a research note on Monday, November 24th. Finally, Wall Street Zen upgraded shares of Lemonade from a “sell” rating to a “hold” rating in a research note on Saturday, August 9th. One research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, one has given a Hold rating and four have given a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $58.57.
Check Out Our Latest Report on LMND
Institutional Investors Weigh In On Lemonade
Several large investors have recently modified their holdings of LMND. Bayforest Capital Ltd acquired a new stake in shares of Lemonade in the third quarter valued at approximately $25,000. Strategic Advocates LLC acquired a new position in shares of Lemonade during the 3rd quarter worth about $33,000. SVB Wealth LLC bought a new stake in Lemonade in the first quarter valued at approximately $26,000. Estabrook Capital Management bought a new stake in Lemonade in the 2nd quarter valued at $44,000. Finally, Tsfg LLC acquired a new stake in shares of Lemonade during the 3rd quarter worth about $54,000. 80.30% of the stock is currently owned by institutional investors.
Lemonade Company Profile
Lemonade, Inc provides various insurance products through various channels in the United States, Europe, and the United Kingdom. Its insurance products include stolen or damaged property, and personal liability that protects its customers if they are responsible for an accident or damage to another person or their property.
Read More
- Five stocks we like better than Lemonade
- What is a Bond Market Holiday? How to Invest and Trade
- Rocket Lab’s Big Rebound? Analysts Suggest the Dip’s a Gift
- 3 Stocks to Consider Buying in October
- Meta’s AI Moment? New SAM 3 Model Has Wall Street Turning Bullish
- How to Plot Fibonacci Price Inflection Levels
- Snowflake Stock: The Dip That Smart Investors Are Buying Right Now
Receive News & Ratings for Lemonade Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lemonade and related companies with MarketBeat.com's FREE daily email newsletter.
